YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1
$150 million of new money to boost liquidity, reduction of pre-transaction debt by over $75 million,andextended maturities dates to Q4 2029
MUNICH,Feb. 19,2025--On February 17,2025,GCL System Integration (GCL SI) achieved a significant milestone by securing the EcoVadis Group-level Silver Medal certification. In its first attempt,GCL SI s
ABU DHABI,UAE,Feb. 19,2025--With the countdown to the 2025 Formula 1® season underway,Ethara has officially launched ticket sales for the FORMULA 1® ETIHAD AIRWAYS ABU DHABI GRAND PRIX 2025,in
STOCKHOLM,Feb. 19,2025-- Sinch (Sinch AB (publ)) – (XSTO: SINCH),which is pioneering the way the world communicates through its digital Customer Communications Cloud,is pleased to provide critical re
- New Product Combines Pink Grapefruit Note with Rare Galaxy Hop; Company Looking to Further Expand Product Reach in Asian Market in 2025 -
